Mulligan Mobilization & Stretching Effects of Cervical

NCT ID: NCT07045974

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-15

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. To evaluate the effectiveness of mulligan mobilization and stretching exercises in reducing pain in individuals with cervical radiculopathy.
2. To evaluate the effectiveness of mulligan mobilization and stretching exercises in reducing disability in individuals with cervical radiculopathy.
3. To evaluate the effectiveness of mulligan mobilization and stretching exercises at improving ranges in individuals with cervical radiculopathy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cervical Radiculopathy is a condition characterized by dysfunction of cervical spinal nerve roots which occurs as a result of compression or inflammatory pathology from a space occupying lesion such as a disc herniation, decreased disc height and degenerative changes of the uncovertebral joints anteriorly and zygoapophyseal joints posteriorly. Cervical radiculopathy constitutes 5%-36% of all radiculopathies. In general, rate of occurrence of cervical radiculopathy is 83/100,000 with an increased prevalence in the fifth decade of life (203/100,000).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Radiculopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A-Mulligan Mobilization

Mulligan SNAGs mobilization technique was applied at level C4/5.

Group Type EXPERIMENTAL

Group A-Mulligan Mobilization

Intervention Type OTHER

Group A will receive Mulligan mobilizations (SNAGs). Mulligan SNAGs mobilization technique was applied at level C4/5. Subjects were placed in sitting position and therapist stood behind the patient with therapist's thumbs on spinous process of particular vertebra. Mobilization was given by active movement followed by passive overpressure based on the movement restricted. The duration of treatment was three sets of ten repetitions each.

Conventional treatment include the following:

Subjects in both the groups were treated with hot pack (20 min), TENS (2 to 10 Hz), and manual traction along with deep neck flexor, and isometric neck strengthening.

Group B-Stretching Exercises

Cervical stretching exercises will be performed.

Group Type EXPERIMENTAL

Group B-Stretching Exercises

Intervention Type OTHER

Group B will receive stretching exercises. Subject was asked to lie supine on the plinth and the head was held at the edge of the plinth by the therapist. Then with one hand the therapist held the neck in cervical lateral flexion to the opposite side so as to achieve the stretching of the trapezius muscle. Myofascial release by applying sustained finger pressure for 5-10 s on the involved trapezius was given. A gentle myofascial stretching force was applied to take up slack and sustained until a release occurred. This protocol comprised four sets of 15 stretches with 3 min rest.

Conventional treatment include the following:

Subjects in both the groups were treated with hot pack (20 min), TENS (2 to 10 Hz), manual traction along with deep neck flexor, and isometric neck strengthening.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group A-Mulligan Mobilization

Group A will receive Mulligan mobilizations (SNAGs). Mulligan SNAGs mobilization technique was applied at level C4/5. Subjects were placed in sitting position and therapist stood behind the patient with therapist's thumbs on spinous process of particular vertebra. Mobilization was given by active movement followed by passive overpressure based on the movement restricted. The duration of treatment was three sets of ten repetitions each.

Conventional treatment include the following:

Subjects in both the groups were treated with hot pack (20 min), TENS (2 to 10 Hz), and manual traction along with deep neck flexor, and isometric neck strengthening.

Intervention Type OTHER

Group B-Stretching Exercises

Group B will receive stretching exercises. Subject was asked to lie supine on the plinth and the head was held at the edge of the plinth by the therapist. Then with one hand the therapist held the neck in cervical lateral flexion to the opposite side so as to achieve the stretching of the trapezius muscle. Myofascial release by applying sustained finger pressure for 5-10 s on the involved trapezius was given. A gentle myofascial stretching force was applied to take up slack and sustained until a release occurred. This protocol comprised four sets of 15 stretches with 3 min rest.

Conventional treatment include the following:

Subjects in both the groups were treated with hot pack (20 min), TENS (2 to 10 Hz), manual traction along with deep neck flexor, and isometric neck strengthening.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants falling in this category would be recruited into the study.

* Both genders
* Age between 20-50 years
* Subjects with neck pain radiating down to the arm
* Patients with positive findings for spurling test, Upper Limb Tension Test (ULTT), cervical distraction test and cervical rotation test towards the symptomatic side
* Subjects who were willing to participate in the study and willing to take treatment for cervical radiculopathy.

Exclusion Criteria

* Participant failing to fall in this category would be excluded of the study.

* Systemic disease potentially affecting the musculoskeletal system Patients experiencing primary shoulder or upper extremity problem of local origin
* Patients with any cardiovascular disorders and respiratory disorders
* Patients with any other pathological conditions involving cervical spine like vertebro basilar insufficiency and canal stenosis
* Patients having osteophytes in cervical vertebrae
* Patients who were undergoing treatment for neck pain with other means of physiotherapy at the time of the study
* Hypermobile joints of cervical vertebrae, Cervical fractures, spinal surgery or other spinal pathologies (i.e. ankylosing spondylitis, spondylolysthesis)
* Peripheral nerve lesions like neurotemesis and axonotemesis
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayesha Sadiq, MSPT (OMPT)

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Leady Reading Hospital (LRH), Hayatabad Medical Complex (HMC)

Peshawar, KPK, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayesha Sadiq, MSPT (OMPT)

Role: CONTACT

03346257484

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr. Hakeem Khan, MS

Role: primary

03363199633

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-01012 Mahnoor Ali

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.